Not done

Not done - ASTRAU

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2017-004206-17-FR

Enrollment

622

Registered

2018-04-09

Start date

2018-06-07

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not done. MedDRA version: 20.1 Level: LLT Classification code 10044528 Term: Traumatic injury System Organ Class: 100000004863

Interventions

Trade Name: PLASMALYTE VIAFLO Product Name: PLASMALYTE VIAFLO Pharmaceutical Form: Solution for infusion INN or Proposed INN: PLASMALYTE VIAFLO Other descriptive name: PLASMALYTE VIAFLO, solution pour

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Not done. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 566 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 56

Exclusion criteria

Exclusion criteria: Not done.

Design outcomes

Primary

Measure	Time frame
Main Objective: Not done.;Secondary Objective: Not done.;Primary end point(s): Not done.;Timepoint(s) of evaluation of this end point: Not done.	—

Secondary

Measure	Time frame
Secondary end point(s): Not done;Timepoint(s) of evaluation of this end point: Not done.	—

Countries

France

Contacts

Public ContactDRCI Hôpital St Louis

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

myriem.carrier@aphp.fr

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026